Porcine-brain-derived peptide complex. Mixture of low-molecular-weight neuropeptides and free amino acids with neurotrophic-mimetic activity.
This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.
Ever Pharma (Austria) product. Approved in ~50 countries (not US/UK) for stroke recovery, traumatic brain injury, vascular dementia, and Alzheimer adjunctive therapy. CARS / CASTA trials show modest functional benefit in stroke. IV/IM administration only.
Not approved in US. Importation for personal use is grey-market. Porcine-derived material has theoretical TSE / allergen concerns. Mechanism is multi-target and ill-defined.
Per-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Pre-filled with this compound's published dose range: 5-30 mL · daily IV/IM, in cycles
Calculator is a discussion tool. Verify reconstitution + dosing with a qualified provider. Stack is not a prescription source. Use sterile technique and inspect every vial.
How much a first cycle actually costs across the channels people use. Pick the protocol length you're considering — Stack multiplies the monthly band by cycle weeks. Same caveats apply: ranges are facts, quality varies, this is not legal advice.
Numbers reflect publicly-advertised price ranges, not vendor quotes. Insurance, prescription costs, and shipping aren't included. Channels marked unavailable are filtered out.
See pharmacies for this compound →Approximate monthly cost across the channels users actually consider — brand FDA-approved retail, US 503A compounding, Mexican pharmacies, MX farmacias magistrales, and the research-grey market. Stack lists ranges, not vendor names. Quality varies wildly across channels — see each band's note.
COFEPRIS-registered for stroke recovery, vascular dementia, traumatic brain injury. Available with MX prescription.
As of 2026-04International mail-order from EU/Russia at higher per-unit cost than MX legitimate channel.
As of 2026-04Approved in EU/MX/RU/CN; not FDA-approved
Cerebrolysin (Cerebrolisina) has been registered with COFEPRIS for decades for stroke recovery, vascular dementia, and traumatic brain injury. Sold in Mexican pharmacies with prescription. Pricing materially lower than international mail-order options.
Cerebrolysin (porcine brain-derived peptide mixture) is approved in Austria, Germany, Russia, China, and ~50 other countries for stroke recovery, vascular dementia, and traumatic brain injury. Never approved in the US.